fbpx

Eiira Classic

4990 kr

A genetic test to prevent hereditary cancer Simple genetic test done at home Discover hereditary risks for the 10 most common cancers Take preventive action

Out of stock

Yes, it is easy. We will post a saliva collection kit and a return envelope to your home via Postnord. You simply spit saliva into the collection tube. If you need help, instructions are enclosed in the kit. Once you have collected saliva, you place the kit in the return envelope, which has a paid return label. You can then drop off the envelope at any Postnord service point.
The only other thing you need to do is to provide your details and our family’s medical history. The tools on our website will help you easily input the information. It is okay if you don’t provide your family medical history because you don’t know or you prefer not to.
The risk for 10 cancer types is mapped out by using the proven risk models and reference risk estimation data that are recommended in Swedish national guidelines. The below information is used as input to the mapping:
  • The results of your genetic tests. You can find more information in the section "What is the technology behind the genetic test?"
  • Your family medical history. Given the limitation of the current genomic science, your genetic test data alone cannot predict all risks. The family’s medical history contains much hereditary information. In some cases, family history alone can predict hereditary cancer risk. Therefore family medical history is used as part of the input.
  • Information on you and your medical history. Personal information such as ethnicity and ancestry roots have an impact on our hereditary risks. Your lifestyle and medical history affect the risk level.
Note that the risks we report are hereditary risks. That is the risk that you inherited from your biological parents.

Behind the test is one of the most advanced techniques called Whole Exome Sequence (WES). First, your saliva sample is analysed and all DNA from the germ cells responsible for generating your proteins is captured. 'Germinal' means only the DNA that you inherited from your parents at fertilisation. The analysis then looks for any pathogenic gene changes (known as variants) in the DNA data (i.e. your entire exome data).

Our report includes 50 genes that are known to cause a significantly increased risk of developing cancer. The selection of these 50 genes is based on Swedish national guidelines.

Because germline DNA remains the same during a person’s lifetime, you do not need to take another genetic test for your whole exome data. As genomic science and cancer prevention measures are constantly being discovered, you can enjoy these new advancements without taking another test.
First of all, we need to understand that the risk is the likelihood of developing cancer:
  • Risk is not a diagnosis.
  • Some people with high risk never have cancer.
  • Similarly, people with low risk can still develop cancer.
Second, there are preventive measures to empower you. The report will inform you of proactive options available in Sweden. For many cancers, over 90% (close to 100% for breast cancers) survive if discovered early. The healthcare system has a number of monitoring programs to discover cancers early. We’ll inform you how to enter the Swedish healthcare system. There are also preventive healthcare partners that we can recommend to you.

What are the ten cancer?

Here is the list of the ten cancers:

Melanoma
Pancreatic
Kidney/Renal
Colorectal cancer
Prostate for men
Ten types of cancer
Thyroid
Breastsfor men and women
Hereditary diffuse gastric cancer
Uterinefor women
Ovarianfor women

Genes associated

To make this assessment, we have analyzed 50 genes in your DNA to identify the possible presence of disease-causing variants that are linked to an increased cancer risk. These genes have been selected based on their association with certain specific cancers or cancer syndromes. The table below shows the genes linked to the 10 different cancers covered by the analysis (i.e. the genes where we know that people carrying a disease-causing variant have an increased risk of cancer).

Cancer typeGenes associated
BreastBRCA1, BRCA2, PALB2, TP53, PTEN, CDH1, STK11, NF1, ATM, CHEK2, BARD1, RAD51C, RAD51D
OvarianBRCA1, BRCA2, PALB2, RAD51C, RAD51D, BRIP1, MLH1, MSH2, EPCAM, MSH6, PMS2
ColonMLH1, MSH2, MSH6, PMS2, EPCAM, APC, MUTYH, STK11, SMAD4, BMPR1A, PTCH, PTEN, NTHL1, POLD1, POLE, MSH3, TP53
ProstateBRCA2, HOXB13, BRCA1, MLH1, MSH2, MSH6, EPCAM, PMS2, ATM, CHEK2, PALB2, TP53
MelanomaCDKN2A, BAP1, CDK4, POT1, TERT, MITF1, MC1R, ASIP, TYR, TYRP1, TP53
Kidney/RenalVHL, FLCN, FH, MET, PTEN, SDHB, BAP1, SDHA, SDHC, SDHD
ThyroidRET, APC, PTEN, DICER1, TP53
UterineMLH1, MSH2, MSH6, PMS2, PTEN
Pancreatic CancerBRCA1, BRCA2, ATM, PALB2, MLH1 , MSH2, EPCAM, MSH6, PMS2, STK11, CDKN2A
Hereditary diffuse gastric cancerCDH1, CTNNA1

How it works

Compare Eiira Classic and Premium

FeaturesEiira ClassicEiira Premium
Risk mapping for the ten most common cancers
Preventive measure for ten most common cancers
Updates for ten most common cancers
Future updates to cover other diseases LimitedUnlimited
Lifetime updates of the latest discoveries in genetic scienceLimitedUnlimited
Possibility to detect rare cancer variants⭐⭐⭐⭐ (medium)⭐⭐⭐⭐⭐ (most)
Genetic Sequencing Technology Whole exome sequencing (WES)Whole Genome Sequencing (WGS)
Choose your Eiira genetic test:
4990 kr
9990 kr

Eiira customers

Check out what others have already done to prevent hereditary cancers with Eiira

Data privacy & security

Eiira takes your data privacy and security seriously

Powered by